MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    blepharoplasty yes or not? a single-centre study on the influence of blepharoplasty on the treatment with botulinum toxin injections.

    A. Trinchillo, N. Cuomo, F. Iorillo, G. de Joanna, F. Habetswallner, M. Esposito (Giugliano in Campania, Italy)

    Objective: To compare the responses to the BoNT injections of patients who underwent or not to blepharoplasty (Blepharoplasty YES/NO), in order to clarify if the…
  • 2023 International Congress

    Pain in Monogenic Parkinson’s disease: A systematic review

    P. Alizadeh, C. Terroba Chambi, V. Bruno (Calgary, Canada)

    Objective: We investigated the hypothesis that genotypes may influence pain phenotype in Parkinson's disease (PD) patients. The presence of pain, its subtypes, severity, and time in relationship…
  • 2023 International Congress

    Rest Tremor in Parkinson’s Disease Is Associated with Increased Ipsilateral DAT Binding

    K. Niemi, J. Sunikka, V. Kaasinen, J. Joutsa (Turku, Finland)

    Objective: To investigate the connection between striatal dopamine transporter binding and cardinal motor symptoms of Parkinson’s disease. Background: The three cardinal motor symptoms of Parkinson’s…
  • 2023 International Congress

    The role of RNA-carrying exosomes in synaptic physiology and in synucleinopathies

    A. Chopra, T. Outeiro (Göttingen, Germany)

    Objective: Our goals were: (i) to characterize the molecular mechanisms associated with the transfer of miRNAs from astrocytes to neuronal synapses via exosomes in transgenic…
  • 2023 International Congress

    Frequency of Parkinson’s Disease in All Case Hospitalization Among Native Hawaiian/Pacific Islanders, Asian American Subgroups and Whites

    M. Bruno, M. Matsunaga, E. Krening, J. Chen, G. Ross (Honolulu, USA)

    Objective: To determine if the proportion of hospitalized patients with Parkinson’s Disease (PD) in Hawaii differs among Native Hawaiians/Pacific Islanders (NHPI), American Asians (AA), and…
  • 2023 International Congress

    Accelerometric Classification of Resting and Postural Tremor in Essential Tremor and Parkinson’s Disease

    C. Hennen, T. Berger, GA. Brandt, JN. Strelow, H. Jergas, JC. Baldermann, MT. Barbe, JN. Petry-Schmelzer, TA. Dembek (Cologne, Germany)

    Objective: To investigate the predictive value of different accelerometry metrics for clinical ratings of Essential Tremor (ET) and tremor in Parkinson’s Disease (PD). Background: To…
  • 2023 International Congress

    Cerebellar ataxia in Hypomyelinating Leukodystrophies: A case series

    J. Ganguly, J. Sinha, P. Basu, M. Tiwari, H. Kumar (Kolkata, India)

    Objective: We present a case series of cerebellar ataxia due to hypomyelinating leukodystrophies (HLDs). Background: HLDs are a group of disorders arising from primary deficit…
  • 2023 International Congress

    Characterisation of the pharmacokinetic profile of L-DOPA in the common marmoset

    D. Bédard, F. Gaudette, F. Beaudry, P. Huot (Montreal, Canada)

    Objective: To determine the pharmacokinetic (PK) profile of L-3,4-dihydroxyphenylalanine (L-DOPA) in the common marmoset (Callithrix jacchus). Background: The common marmoset has been used to model…
  • 2023 International Congress

    Asymmetry of striatal dopaminergic function in essential tremor is associated with kinetic tremor asymmetry

    A. Kuusela, E. Honkanen, E. Jaakkola, E. Mäkinen, M. Eklund, S. Nuuttila, K-M. Murtomäki, T. Mertsalmi, T. Noponen, J. Joutsa, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: To investigate possible dopaminergic pathophysiology of essential tremor (ET) by focusing on tremor asymmetry. Background: Essential tremor (ET) is considered a non-dopaminergic movement disorder.…
  • 2023 International Congress

    Real-World Utilization of Istradefylline Among Patients with Parkinson’s Disease

    M. Rezak, J. Qian, Y. Zhao, A. Silverstein, J. Chamber, J. Swindle, N. Kronfeld, P. Lewitt (Hoffman estates, USA)

    Objective: This study examined real-world utilization of istradefylline and other PD-related medications before and after istradefylline initiation. Background: Istradefylline is indicated as adjunctive therapy to…
  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley